In recent study, the Elf5–2b variant was distinguished as a major form of Elf5 expressed in human, so this isoform was chosen in our study as well as in another paper, in which Elf5 was demonstrated to be an inhibitor of EMT in breast cancer [12]. This evidence concerns the gene ELF5 and breast cancer.